160 related articles for article (PubMed ID: 32884133)
1. Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations.
Zenner K; Jensen DM; Cook TT; Dmyterko V; Bly RA; Ganti S; Mirzaa GM; Dobyns WB; Perkins JA; Bennett JT
Genet Med; 2021 Jan; 23(1):123-130. PubMed ID: 32884133
[TBL] [Abstract][Full Text] [Related]
2. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
3. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
[TBL] [Abstract][Full Text] [Related]
4. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy.
Palmieri M; Di Sarno L; Tommasi A; Currò A; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Fallerini C; Arzini A; Pinto A; Vaghi M; Renieri A
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):740-744. PubMed ID: 32858245
[TBL] [Abstract][Full Text] [Related]
5. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
[TBL] [Abstract][Full Text] [Related]
6. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations.
Brouillard P; Schlögel MJ; Homayun Sepehr N; Helaers R; Queisser A; Fastré E; Boutry S; Schmitz S; Clapuyt P; Hammer F; Dompmartin A; Weitz-Tuoretmaa A; Laranne J; Pasquesoone L; Vilain C; Boon LM; Vikkula M
Orphanet J Rare Dis; 2021 Jun; 16(1):267. PubMed ID: 34112235
[TBL] [Abstract][Full Text] [Related]
7. The utility of cerebrospinal fluid-derived cell-free DNA in molecular diagnostics for the
Chen WL; Pao E; Owens J; Glass I; Pritchard C; Shirts BH; Lockwood C; Mirzaa GM
Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483878
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.
Luks VL; Kamitaki N; Vivero MP; Uller W; Rab R; Bovée JV; Rialon KL; Guevara CJ; Alomari AI; Greene AK; Fishman SJ; Kozakewich HP; Maclellan RA; Mulliken JB; Rahbar R; Spencer SA; Trenor CC; Upton J; Zurakowski D; Perkins JA; Kirsh A; Bennett JT; Dobyns WB; Kurek KC; Warman ML; McCarroll SA; Murillo R
J Pediatr; 2015 Apr; 166(4):1048-54.e1-5. PubMed ID: 25681199
[TBL] [Abstract][Full Text] [Related]
9. Somatic activating
Zenner K; Jensen DM; Dmyterko V; Shivaram GM; Myers CT; Paschal CR; Rudzinski ER; Pham MM; Cheng VC; Manning SC; Bly RA; Ganti S; Perkins JA; Bennett JT
HGG Adv; 2022 Apr; 3(2):100101. PubMed ID: 35373151
[TBL] [Abstract][Full Text] [Related]
10. Therapy Monitoring of EGFR-Positive Non-Small-Cell Lung Cancer Patients Using ddPCR Multiplex Assays.
de Kock R; van den Borne B; Youssef-El Soud M; Belderbos H; Brunsveld L; Scharnhorst V; Deiman B
J Mol Diagn; 2021 Apr; 23(4):495-505. PubMed ID: 33486072
[TBL] [Abstract][Full Text] [Related]
11. Urine cell-free DNA is a biomarker for nephroblastomatosis or Wilms tumor in PIK3CA-related overgrowth spectrum (PROS).
Biderman Waberski M; Lindhurst M; Keppler-Noreuil KM; Sapp JC; Baker L; Gripp KW; Adams DM; Biesecker LG
Genet Med; 2018 Sep; 20(9):1077-1081. PubMed ID: 29300373
[TBL] [Abstract][Full Text] [Related]
12. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
[TBL] [Abstract][Full Text] [Related]
13. Optimized (Pre) Analytical Conditions and Workflow for Droplet Digital PCR Analysis of Cell-Free DNA from Patients with Suspected Lung Carcinoma.
de Kock R; Deiman B; Kraaijvanger R; Scharnhorst V
J Mol Diagn; 2019 Sep; 21(5):895-902. PubMed ID: 31229652
[TBL] [Abstract][Full Text] [Related]
14. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
[TBL] [Abstract][Full Text] [Related]
15. Validation of targeted next-generation sequencing of cell-free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation.
Neil AJ; Chukwueke UN; Hoover N; Marris SRN; Rojas-Rudilla V; Manning DK; Mito JK; Cibas ES; Sholl LM
Cancer Cytopathol; 2024 Apr; 132(4):214-223. PubMed ID: 37812603
[TBL] [Abstract][Full Text] [Related]
16. Denaturation-Enhanced Droplet Digital PCR for Liquid Biopsies.
Fitarelli-Kiehl M; Yu F; Ashtaputre R; Leong KW; Ladas I; Supplee J; Paweletz C; Mitra D; Schoenfeld JD; Parangi S; Makrigiorgos GM
Clin Chem; 2018 Dec; 64(12):1762-1771. PubMed ID: 30274976
[TBL] [Abstract][Full Text] [Related]
17. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
[TBL] [Abstract][Full Text] [Related]
18. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
[TBL] [Abstract][Full Text] [Related]
19. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Kim H; Faughnan ME;
Mol Genet Genomic Med; 2018 May; 6(3):350-356. PubMed ID: 29932521
[TBL] [Abstract][Full Text] [Related]
20. Detection of somatic variants and
Sung JS; Chong HY; Kwon NJ; Kim HM; Lee JW; Kim B; Lee SB; Park CW; Choi JY; Chang WJ; Choi YJ; Lee SY; Kang EJ; Park KH; Kim YH
Oncotarget; 2017 Dec; 8(63):106901-106912. PubMed ID: 29290998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
